Nature Medicine | Spoonful of Medicine
Geron abandons stem cell research
Crossposted from Nature’s news blog A company that pioneered embryonic stem cell research is walking out on the field it helped to create. Geron, based in Menlo Park, California, announced yesterday that it would kill off its stem cell program — and its landmark clinical trial of a treatment for spinal cord injuries — so that it can focus on cancer therapies. For supporters of the technology, Geron’s exit is a blow. “This is very unfortunate for the field,” says Robert Lanza, chief scientific officer of Advanced Cell Technology, the only other embryonic stem cell company with regulatory approval to
Recent comments
Real-time tissue analysis could guide brain tumor surgery
Bundled RNA balls silence brain cancer gene expression
Ebola outbreak in West Africa lends urgency to recently-funded research